These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 11750231)

  • 1. Palliation of oesophageal cancer.
    Mason R
    Surg Oncol; 2001 Nov; 10(3):123-6. PubMed ID: 11750231
    [No Abstract]   [Full Text] [Related]  

  • 2. Cancer in the oesophagus--palliation with laser or endoprosthesis.
    Lambert R
    Baillieres Clin Gastroenterol; 1987 Oct; 1(4):905-15. PubMed ID: 2452662
    [No Abstract]   [Full Text] [Related]  

  • 3. Esophagogastric cancer--time to change the paradigm.
    O'Sullivan GC; Shanahan F
    Am J Gastroenterol; 2000 Sep; 95(9):2153-4. PubMed ID: 11007209
    [No Abstract]   [Full Text] [Related]  

  • 4. Acceptable results after self-expanding metallic stent treatment for dysphagia in non-resectable oesophageal cancer.
    Bjerring OS; Pless T; Fristrup C; Mortensen MB
    Dan Med J; 2012 Jun; 59(6):A4459. PubMed ID: 22677249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Esophageal and esophagogastric junction cancers.
    Ajani JA; Barthel JS; Bentrem DJ; D'Amico TA; Das P; Denlinger CS; Fuchs CS; Gerdes H; Glasgow RE; Hayman JA; Hofstetter WL; Ilson DH; Keswani RN; Kleinberg LR; Korn WM; Lockhart AC; Mulcahy MF; Orringer MB; Osarogiagbon RU; Posey JA; Sasson AR; Scott WJ; Shibata S; Strong VE; Varghese TK; Warren G; Washington MK; Willett C; Wright CD;
    J Natl Compr Canc Netw; 2011 Aug; 9(8):830-87. PubMed ID: 21900218
    [No Abstract]   [Full Text] [Related]  

  • 6. Optimal management of esophageal adenocarcinoma: should we be CROSS?
    Smyth EC; Waddell TS; Cunningham D
    J Clin Oncol; 2014 Sep; 32(27):3080-1. PubMed ID: 25071100
    [No Abstract]   [Full Text] [Related]  

  • 7. Chemotherapy versus self-expanding metal stent as primary treatment of severe dysphagia from unresectable oesophageal or gastro-oesophageal junction cancer.
    Touchefeu Y; Archambeaud I; Landi B; Lièvre A; Lepère C; Rougier P; Mitry E
    Dig Liver Dis; 2014 Mar; 46(3):283-6. PubMed ID: 24268567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benign complications of expandable metal stents used in the palliation of oesophageal carcinoma: two case reports.
    Metcalfe MJ; Steger AC; Leslie A
    Br J Radiol; 2004 Mar; 77(915):245-7. PubMed ID: 15020368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cancer of the esophagus: therapeutic results].
    Pelletier LC; Bruneau J; Cholette JP; Fauteux JP
    Can J Surg; 1972 Jan; 15(1):30-6. PubMed ID: 5009460
    [No Abstract]   [Full Text] [Related]  

  • 10. Early diagnosis and management of esophageal and gastric cancer.
    Lang GD; Konda VJ
    Minerva Gastroenterol Dietol; 2013 Dec; 59(4):357-76. PubMed ID: 24212354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reply to E. C. Smyth et al.
    Hulshof MC; Oppedijk V; van der Gaast A
    J Clin Oncol; 2014 Sep; 32(27):3081-2. PubMed ID: 25071131
    [No Abstract]   [Full Text] [Related]  

  • 12. Reply to E. C. Smyth et al.
    Mamon HJ; Tepper JE
    J Clin Oncol; 2014 Sep; 32(27):3082. PubMed ID: 25071102
    [No Abstract]   [Full Text] [Related]  

  • 13. Combination chemoradiation therapy: the whole is more than the sum of the parts.
    Mamon HJ; Tepper JE
    J Clin Oncol; 2014 Feb; 32(5):367-9. PubMed ID: 24419110
    [No Abstract]   [Full Text] [Related]  

  • 14. Low morbidity after palliation of obstructing gastro-oesophageal adenocarcinoma to restore swallowing function.
    Kofoed SC; Lundsgaard M; Ellemann AC; Svendsen LB
    Dan Med J; 2012 Jun; 59(6):A4434. PubMed ID: 22677236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome of neoadjuvant therapies for cancer of the oesophagus or gastro-oesophageal junction based on a national data registry.
    Klevebro F; Lindblad M; Johansson J; Lundell L; Nilsson M
    Br J Surg; 2016 Dec; 103(13):1864-1873. PubMed ID: 27689845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant (postoperative) therapy for esophageal cancer.
    Ku GY; Ilson DH
    Thorac Surg Clin; 2013 Nov; 23(4):525-33. PubMed ID: 24199702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-expanding metal stents for the palliation of dysphagia due to inoperable oesophageal carcinoma.
    Ellul JP; Watkinson A; Khan RJ; Adam A; Mason RC
    Br J Surg; 1995 Dec; 82(12):1678-81. PubMed ID: 8548240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oesophageal carcinoma: combined chemo- and radiotherapy.
    Dehn TC; Jamieson GG; Gill PG
    Br J Surg; 1988 Jun; 75(6):621. PubMed ID: 3395833
    [No Abstract]   [Full Text] [Related]  

  • 19. Malignant dysphagia: palliation with esophageal stents--long-term results with 100 patients.
    Coyle WJ; Lawson JM
    Gastrointest Endosc; 1999 Jul; 50(1):134-5. PubMed ID: 10428620
    [No Abstract]   [Full Text] [Related]  

  • 20. Palliative endoscopic dilatation in carcinoma of the esophagus and esophagogastric junction.
    Lundell L; Leth R; Lind T; Lönroth H; Sjövall M; Olbe L
    Acta Chir Scand; 1989 Mar; 155(3):179-84. PubMed ID: 2472723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.